The Proteomics Market is predicted to reach USD 21.87 billion by 2021 with a CAGR of 11.7 % according to the Market Data Forecast.

The Proteomics Market is predicted to reach USD 21.87 billion by 2021 with a CAGR of 11.7 % according to the Market Data Forecast.

ID: 2001 | May 2017 | Region: Global

The Proteomics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report Global Proteomics Market was worth USD 12.54 billion in 2016 and is expected to reach USD 21.87 billion by 2021 with a CAGR of 11.7 %. The market is segmented by Instrument (Protein Microarrays(Biochips, and Microarray instruments), Spectroscopy, X-ray crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, and protein fractionation), Reagent(Protein Microarray Reagents, Spectroscopy Reagents, X-Ray Crystallography Reagents, Chromatography Reagents, Electrophoresis Reagents Immunoassay Reagents, Protein Fractionation Reagent), Service & Software(Analytical Laboratory Services, Data Analysis & Maintenance and Quantitation Services), Application (Diagnostics, Drug Discovery and other proteomic Application) and by Region– Global Industry Analysis, Size, Share, Growth, Trends and forecasts (2016-2021). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Increasing requirement for customized medicine, R&D use, technological advancements, and increased financing for proteomics ventures are some of the factors driving the market. However, decreasing funds in key markets, sequestration cuts in the U.S. and decreased assets for proteomics research, high cost of instruments and hardware, and lack of talented scientists are some of the major factors restraining the market.

Clinical Diagnostics segment accounted for largest share in 2015 owing to the increased understanding of structures of protein expression for drug development and diseases. Drug discovery segment is expected to increase at the highest CAGR owing to continuous search for efficient ways to deliver enhanced drugs.

Geographically, North America dominated the market owing to the availability of advanced research facilities. Asia-Pacific is expected to increase at highest CAGR owing to the improving medical infrastructure, growing influence of key players and growing economies.

Some key players in this market are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.

Browse through the full report at “” and checkout our recent reports in the Biotechnology category at “”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)

Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.